Latest Headlines
PR Newswire
XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication
9 小时前
PR Newswire
Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
9 小时前
PR Newswire
Timekettle Makes Its First Appearance at MWC 2026, Highlighting the Highly Responsive W4 AI Interpreter Earbuds
10 小时前
It's better on the app
👈 Scan the QR code to download